Related Experiment Video
Updated: Oct 11, 2025

Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins
Published on: June 14, 2018
Into the multiverse of gene edited NK cell-based therapeutic strategies
Benjamin H Goldenson1, Dan S Kaufman1
1Department of Medicine, Division of Regenerative Medicine, University of California, San Diego, La Jolla, CA, USA.
Abstract:
In this issue of Cell Stem Cell, Woan et al., (2021) investigate the anti-cancer activity of triple gene edited iPSC-derived natural killer (NK) cells and demonstrate that expression of a modified CD16a and interleukin (IL)-15 receptor combined with knockout of CD38 improves NK cell-mediated activity against leukemia and multiple myeloma.
Insights
Triple gene edited induced pluripotent stem cell-derived natural killer (NK) cells show enhanced anti-cancer activity. This triple gene editing approach improves NK cell effectiveness against leukemia and multiple myeloma.
Area of Science:
- Immunotherapy
- Cancer Biology
- Stem Cell Therapy
Background:
- Natural killer (NK) cells are crucial for innate immunity and cancer surveillance.
- Gene editing holds promise for enhancing NK cell-based cancer therapies.
- Leukemia and multiple myeloma remain significant challenges in oncology.
Purpose of the Study:
- To investigate the anti-cancer potential of triple gene edited induced pluripotent stem cell (iPSC)-derived NK cells.
- To evaluate the impact of specific genetic modifications on NK cell function.
- To assess the efficacy of these engineered NK cells against hematological malignancies.
Main Methods:
- Generation of NK cells from iPSCs.
- Triple gene editing of iPSC-derived NK cells, including modification of CD16a and IL-15 receptor, and knockout of CD38.
- In vitro and in vivo assessment of NK cell-mediated anti-cancer activity.
Main Results:
- Triple gene edited NK cells exhibited enhanced cytotoxic activity.
- The specific genetic modifications (modified CD16a, IL-15 receptor, CD38 knockout) improved NK cell persistence and function.
- Demonstrated significant anti-leukemia and anti-multiple myeloma activity.
Conclusions:
- Triple gene edited iPSC-derived NK cells represent a promising cellular immunotherapy strategy.
- This approach significantly boosts NK cell-mediated anti-cancer effects.
- Further development could lead to novel treatments for leukemia and multiple myeloma.

